Objective. The aim of the present study was to determine the irisin levels in patients with the type 1 diabetes mellitus (T1DM) and to examine the relation of irisin levels with the inflammation and autoimmunity.
Methods. This study included 35 cases diagnosed with T1DM and 36 healthy volunteers. Antiglutamic acid decarboxylase (anti-GAD), islet cell antibody (ICA), and insulin autoantibody levels were measured in patients at the time when they were included into the study and recorded from the patient files. Serum irisin levels were measured by ELISA kit.
Results. The median irisin levels were determined higher in T1DM group compared to the control one (6.8 ng/ml vs. 4.8 ng/ml, p=0.022; respectively). Median irisin levels were higher in anti-GAD (p=0.022) and ICA (p=0.044) positive groups compared to negative groups. In T1DM group, irisin levels displayed positive correlation with glycosylated hemoglobin (HbA1c) (r=0.377, p<0.001) and anti-GAD (r=0.392, p=0.020) and negative correlation with creatinine (r=-0390, p=0.021). In multivariate regression model, HbA1c (B±SE: 2.76±17683, p<0.001), and anti-GAD (B±SE: 2.311±0.610, p=0.001) were determined as independent predictors for predicting the irisin levels.
Conclusion. In patients with T1DM, which chronic inflammation and autoimmunity take part in their etiopathogenesis, anti-GAD levels were an independent risk factor for the irisin. Th is may suggest that factors such as inflammation and autoimmunity can be effective in the synthesis of irisin.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Affourtit C Quinlan CL Brand MD. Measurement of proton leak and electron leak in isolated mitochondria. Methods Mol Biol 810 165-182 2012.
Ates I Altay M Topcuoglu C Yilmaz FM. Circulating levels of irisin is elevated in hypothyroidism a case-control study. Arch Endocrinol Metab 60 95-100 2016.
Aydin S. Three new players in energy regulation: preptin adropin and irisin. Peptides 56 94-110 2014.
Aydin S Kuloglu T Aydin S Kalayci M Yilmaz M Cakmak T Albayrak S Gungor S Colakoglu N Ozercan IH. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 61 130-136 2014.
Bostrom P Wu J Jedrychowski MP Korde A Ye L Lo JC Rasbach KA Bostrom EA Choi JH Long JZ Kajimura S Zingaretti MC Vind BF Tu H Cinti S Hojlund K Gygi SP Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 463-468 2012.
Choi YK Kim MK Bae KH Seo HA Jeong JY Lee WK Kim JG Lee IK Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100 96-101 2013.
Crujeiras AB Pardo M Arturo RR Navas-Carretero S Zulet MA Martinez JA Casanueva FF. Longitudinal variation of circulating irisin aft er an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol 26 198-207 2014.
De Naeyer H Ouwens DM Van Nieuwenhove Y Pattyn P Hart LM Kaufman JM Sell H Eckel J Cuvelier C Taes YE Ruige JB. Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase mitochondrial content and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men. Obes Facts 4 407-416 2011.
Enerback S. Brown adipose tissue in humans. Int J Obes (Lond) 34 Suppl 1 S43-46 2010.
Espes D Lau J Carlsson PO. Increased levels of irisin in people with long-standing Type 1 diabetes. Diabet Med 32 1172-1176 2015.
Febbraio MA. Exercise and infl ammation. J Appl Physiol (1985) 103 376-377 2007.
Handschin C. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha in muscle links metabolism to infl ammation. Clin Exp Pharmacol Physiol 36 1139-1143 2009.
Huh JY Panagiotou G Mougios V Brinkoetter M Vamvini MT Schneider BE Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61 1725-1738 2012.
Jastroch M Divakaruni AS Mookerjee S Treberg JR Brand MD. Mitochondrial proton and electron leaks. Essays Biochem 47 53-67 2010.
Liu JJ Wong MD Toy WC Tan CS Liu S Ng XW Tavintharan S Sum CF Lim SC. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27 365-369 2013.
Liu JJ Liu S Wong MD Tan CS Tavintharan S Sum CF Lim SC. Relationship between circulating irisin renal function and body composition in type 2 diabetes. J Diabetes Complications 28 208-213 2014.
Moreno-Navarrete JM Ortega F Serrano M Guerra E Pardo G Tinahones F Ricart W Fernandez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98 E769-778 2013.
Park KH Zaichenko L Peter P Davis CR Crowell JA Mantzoros CS. Diet quality is associated with circulating Creactive protein but not irisin levels in humans. Metabolism 63 233-241 2014.
Pedersen BK Steensberg A Fischer C Keller C Keller P Plomgaard P Febbraio M Saltin B. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24 113-119 2003.
Sesti G Andreozzi F Fiorentino TV Mannino GC Sciacqua A Marini MA Perticone F. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol 51 705-713 2014.Staiger H Bohm A Scheler M Berti L Machann J Schick F Machicao F Fritsche A Stefan N Weigert C Krook A Haring HU de Angelis MH. Common genetic variation in the human FNDC5 locus encoding the novel muscle-derived ‘browning’ factor irisin determines insulin sensitivity. PLoS One 8 e61903 2013.
Wen MS Wang CY Lin SL Hung KC. Decrease in irisin in patients with chronic kidney disease. PLoS One 8 e64025 2013.
Yan B Shi X Zhang H Pan L Ma Z Liu S Liu Y Li X Yang S Li Z. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One 9 e94235 2014.